Skip to Content

Allergan, Inc.

Company NameAllergan, Inc.
Stock SymbolAGN
Class PeriodFebruary 25, 2014 to April 21, 2014
Lead Plaintiff Motion DeadlineFebruary 16, 2015
CourtUSDC Central District of California

The Firm is investigating potential claims on behalf of persons who sold the common stock of Allergan, Inc. (NYSE:AGN) between February 25, 2014 and April 21, related to alleged violations of federal securities laws by Valeant Pharmaceuticals International, Inc. and Pershing Square Capital Management L.P., among others. Investors who have losses of $100,000 or more are encouraged to contact the firm for more information.

Submit Your Information

If you suffered a loss on your Allergan, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd